Literature DB >> 34370156

The influence of an enamine usnic acid derivative (a tyrosyl-DNA phosphodiesterase 1 inhibitor) on the therapeutic effect of topotecan against transplanted tumors in vivo.

V P Nikolin1, N A Popova1,2, V I Kaledin1, O A Luzina3, A L Zakharenko4, N F Salakhutdinov3,2, O I Lavrik5,6,7.   

Abstract

Tyrosyl-DNA phosphodiesterase 1 (Tdp1) is a repair enzyme for 3'-end DNA lesions, predominantly stalled DNA-topoisomerase 1 (Top1) cleavage complexes. Tdp1 is a promising target for anticancer therapy based on DNA damage caused by Top1 poisoning. Earlier, we have reported about usnic acid enamine derivatives that are Tdp1 inhibitors sensitizing tumor cells to the action of Top1 poison (Zakharenko in J Nat Prod 79:2961-2967, 2016). In the present work, we showed a sensitizing effect of an enamine derivative of usnic acid (when administered intragastrically) on Lewis lung carcinoma in mice in combination with topotecan (TPT, Top1 poison used in the clinic). In the presence of the usnic acid derivative, both the volume of the primary tumor and the number of metastases significantly diminished. The absence of acute toxicity of this compound was demonstrated, as was the importance of the method of its administration for the manifestation of the sensitizing properties.
© 2021. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  DNA repair enzymes; Enamine usnic acid derivative; Lewis lung carcinoma; Tdp1 inhibitor; Topotecan

Year:  2021        PMID: 34370156     DOI: 10.1007/s10585-021-10113-y

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  43 in total

1.  Mechanism-informed Repurposing of Minocycline Overcomes Resistance to Topoisomerase Inhibition for Peritoneal Carcinomatosis.

Authors:  Huang-Chiao Huang; Joyce Liu; Yan Baglo; Imran Rizvi; Sriram Anbil; Michael Pigula; Tayyaba Hasan
Journal:  Mol Cancer Ther       Date:  2017-11-22       Impact factor: 6.261

2.  Yeast gene for a Tyr-DNA phosphodiesterase that repairs topoisomerase I complexes.

Authors:  J J Pouliot; K C Yao; C A Robertson; H A Nash
Journal:  Science       Date:  1999-10-15       Impact factor: 47.728

3.  TDP1 overexpression in human cells counteracts DNA damage mediated by topoisomerases I and II.

Authors:  Hans U Barthelmes; Michael Habermeyer; Morten O Christensen; Christian Mielke; Heidrun Interthal; Jeffrey J Pouliot; Fritz Boege; Doris Marko
Journal:  J Biol Chem       Date:  2004-10-19       Impact factor: 5.157

Review 4.  Tyrosyl-DNA phosphodiesterase 1 targeting for modulation of camptothecin-based treatment.

Authors:  G L Beretta; G Cossa; L Gatti; F Zunino; P Perego
Journal:  Curr Med Chem       Date:  2010       Impact factor: 4.530

Review 5.  Inhibiting the DNA damage response as a therapeutic manoeuvre in cancer.

Authors:  N J Curtin
Journal:  Br J Pharmacol       Date:  2013-08       Impact factor: 8.739

6.  TDP1 facilitates chromosomal single-strand break repair in neurons and is neuroprotective in vivo.

Authors:  Sachin Katyal; Sherif F el-Khamisy; Helen R Russell; Yang Li; Limei Ju; Keith W Caldecott; Peter J McKinnon
Journal:  EMBO J       Date:  2007-10-04       Impact factor: 11.598

7.  Engineered resistance to camptothecin and antifolates by retroviral coexpression of tyrosyl DNA phosphodiesterase-I and thymidylate synthase.

Authors:  Michael C Nivens; Takita Felder; Amanda H Galloway; Maria Marjorette O Pena; Jeffery J Pouliot; H Trent Spencer
Journal:  Cancer Chemother Pharmacol       Date:  2003-11-07       Impact factor: 3.333

8.  TDP1 deficiency sensitizes human cells to base damage via distinct topoisomerase I and PARP mechanisms with potential applications for cancer therapy.

Authors:  Meryem Alagoz; Owen S Wells; Sherif F El-Khamisy
Journal:  Nucleic Acids Res       Date:  2013-12-13       Impact factor: 16.971

9.  Dysregulated human Tyrosyl-DNA phosphodiesterase I acts as cellular toxin.

Authors:  Selma M Cuya; Evan Q Comeaux; Keith Wanzeck; Karina J Yoon; Robert C A M van Waardenburg
Journal:  Oncotarget       Date:  2016-12-27

Review 10.  DNA repair in cancer initiation, progression, and therapy-a double-edged sword.

Authors:  Katarzyna Kiwerska; Krzysztof Szyfter
Journal:  J Appl Genet       Date:  2019-08-30       Impact factor: 3.240

View more
  2 in total

1.  Adamantane-Monoterpenoid Conjugates Linked via Heterocyclic Linkers Enhance the Cytotoxic Effect of Topotecan.

Authors:  Aldar A Munkuev; Nadezhda S Dyrkheeva; Tatyana E Kornienko; Ekaterina S Ilina; Dmitry I Ivankin; Evgeniy V Suslov; Dina V Korchagina; Yuriy V Gatilov; Alexandra L Zakharenko; Anastasia A Malakhova; Jóhannes Reynisson; Konstantin P Volcho; Nariman F Salakhutdinov; Olga I Lavrik
Journal:  Molecules       Date:  2022-05-24       Impact factor: 4.927

2.  New Hybrid Compounds Combining Fragments of Usnic Acid and Thioether Are Inhibitors of Human Enzymes TDP1, TDP2 and PARP1.

Authors:  Nadezhda S Dyrkheeva; Aleksandr S Filimonov; Olga A Luzina; Kristina A Orlova; Irina A Chernyshova; Tatyana E Kornienko; Anastasia A Malakhova; Sergey P Medvedev; Alexandra L Zakharenko; Ekaterina S Ilina; Rashid O Anarbaev; Konstantin N Naumenko; Kristina V Klabenkova; Ekaterina A Burakova; Dmitry A Stetsenko; Suren M Zakian; Nariman F Salakhutdinov; Olga I Lavrik
Journal:  Int J Mol Sci       Date:  2021-10-20       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.